Recent attempts relied on the use of a [111In]anti-claudin-4 mAb for diagnosis of pancreatic ductal carcinomas [29], or a [64Cu]-labeled CPE fragment that has been used for ovarian cancer diagnosis [30]. This evidence concerns the gene CLDN4 and pancreatic ductal adenocarcinoma.